Antineoplastic treatment with crizotinib during pregnancy: a case report-Reference-Cited by-同舟云学术

登录注册会员服务联系我们

Antineoplastic treatment with crizotinib during pregnancy: a case report

Published:2018-08-11 Issue:1 Volume:58 Page:121-122
ISSN:0284-186X
Container-title:Acta Oncologica
language:en
Short-container-title:Acta Oncologica

Author:

Jensen Kristian H.¹,Persson Gitte¹,Storgaard Lone²,Nielsen Birgitte B.²,Pedersen Berit W.²,Maroun Lisa L.³,Huitema Alwin⁴⁵,Pøhl Mette¹

Affiliation:

1. Department of Oncology, Rigshospitalet Copenhagen University Hospital, Copenhagen, Denmark;

2. Department of Obstetrics, Rigshospitalet Copenhagen University Hospital, Copenhagen, Denmark;

3. Department of Pathology, Rigshospitalet Copenhagen University Hospital, Copenhagen, Denmark;

4. Department of Pharmacy and Pharmacology, The Netherlands Cancer Institute, Amsterdam, The Netherlands;

5. Department of Clinical Pharmacy, University Medical Center Utrecht Utrecht University, Utrecht, The Netherlands

Publisher

Informa UK Limited

Subject

Radiology, Nuclear Medicine and imaging,Oncology,Hematology,General Medicine

Link

https://www.tandfonline.com/doi/pdf/10.1080/0284186X.2018.1497302

Reference6 articles.

1. Clinicopathologic Features of NSCLC Diagnosed During Pregnancy or the Peripartum Period in the Era of Molecular Genotyping

2. Editor’s Highlight: Placental Disposition and Effects of Crizotinib: An Ex Vivo Study in the Isolated Dual-Side Perfused Human Cotyledon

3. Increased oral availability and brain accumulation of the ALK inhibitor crizotinib by coadministration of the P-glycoprotein (ABCB1) and breast cancer resistance protein (ABCG2) inhibitor elacridar

4. Ovarian stimulation in young adult cancer survivors on targeted cancer therapies

Cited by 11 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Lung Cancer Oncogene-Directed Therapy, Fertility, and Pregnancy;Journal of Thoracic Oncology;2024-06

2. Treating anaplastic lymphoma kinase (ALK) fusion-driven metastatic non-small cell lung cancer (NSCLC) with alectinib through pregnancy;BMJ Case Reports;2024-03

3. ALK Rearrangement Positive Lung Adenocarcinoma in Pregnancy Treated With Alectinib: A Case Report;Clinical Lung Cancer;2023-11

4. Clinical Features and Management of Lung Cancer During Pregnancy: A Narrative Review Based on Reported Cases;Women's Health Reports;2023-11-01

5. Predicting fetal exposure of crizotinib during pregnancy: Combining human ex vivo placenta perfusion data with physiologically-based pharmacokinetic modeling;Toxicology in Vitro;2022-12

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号京ICP备18003416号-3